Macrogenics Inc (MGNX)
16.08
-0.02
(-0.12%)
USD |
NASDAQ |
Apr 18, 16:00
16.08
0.00 (0.00%)
After-Hours: 20:00
Macrogenics Shareholders Equity (Quarterly): 152.61M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 152.61M |
September 30, 2023 | 193.98M |
June 30, 2023 | 171.54M |
March 31, 2023 | 109.27M |
December 31, 2022 | 142.01M |
September 30, 2022 | 122.96M |
June 30, 2022 | 142.48M |
March 31, 2022 | 178.21M |
December 31, 2021 | 239.62M |
September 30, 2021 | 291.44M |
June 30, 2021 | 319.04M |
March 31, 2021 | 350.53M |
December 31, 2020 | 295.88M |
September 30, 2020 | 291.58M |
June 30, 2020 | 247.78M |
March 31, 2020 | 190.57M |
December 31, 2019 | 230.63M |
September 30, 2019 | 255.20M |
June 30, 2019 | 294.45M |
March 31, 2019 | 320.62M |
December 31, 2018 | 242.88M |
September 30, 2018 | 282.64M |
Date | Value |
---|---|
June 30, 2018 | 312.04M |
March 31, 2018 | 247.28M |
December 31, 2017 | 299.24M |
September 30, 2017 | 189.46M |
June 30, 2017 | 231.35M |
March 31, 2017 | 234.64M |
December 31, 2016 | 268.75M |
September 30, 2016 | 300.10M |
June 30, 2016 | 329.98M |
March 31, 2016 | 286.26M |
December 31, 2015 | 313.34M |
September 30, 2015 | 339.33M |
June 30, 2015 | 211.69M |
March 31, 2015 | 230.99M |
December 31, 2014 | 121.29M |
September 30, 2014 | 139.09M |
June 30, 2014 | 141.98M |
March 31, 2014 | 153.22M |
December 31, 2013 | 78.91M |
September 30, 2013 | -4.048M |
June 30, 2013 | -10.93M |
December 31, 2012 | -8.237M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
109.27M
Minimum
Mar 2023
350.53M
Maximum
Mar 2021
222.10M
Average
230.63M
Median
Dec 2019
Shareholders Equity (Quarterly) Benchmarks
Allurion Technologies Inc | -70.49M |
United Therapeutics Corp | 5.985B |
MEI Pharma Inc | 59.49M |
Heron Therapeutics Inc | -33.97M |
Marinus Pharmaceuticals Inc | 16.76M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 298.42M |
Total Liabilities (Quarterly) | 145.80M |
Current Ratio | 4.480 |